Culprit-lesion-only versus multivessel revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction: A Korean Acute Myocardial Infarction Registry-based analysis

Hyun Su Jo, Jong Seon Park, Jang Won Sohn, Joon Cheol Yoon, Chang Woo Sohn, Sang Hee Lee, Geu Ru Hong, Dong Gu Shin, Young Jo Kim, Myung Ho Jeong, Shung Chull Chae, Seung Ho Hur, Taek Jong Hong, In Whan Seong, Jei Keon Chae, Jay Young Rhew, In Ho Chae, Myeong Chan Cho, Jang Ho Bae, Seung-Woon RhaChong Jin Kim, Dong Hoon Choi, Yang Soo Jang, Jung Han Yoon, Wook Sung Chung, Ki Bae Seung, Seung Jung Park

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background and Objectives: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, complete revascularization (CR) for non-culprit lesions is not routinely recommended. The aim of this study was to compare the clinical outcomes of multivessel compared with infarct-related artery (IRA)-only revascularization in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI. Subjects and Methods: From the Korean Acute Myocardial Infarction Registry (KAMIR) database, 1,094 STEMI patients with multivessel disease who underwent primary PCI with drug-eluting stents were enrolled in this study. The patients were divided into two groups: culprit-vesselonly revascularization (COR, n=827) group; multivessel revascularization, including non-IRA (MVR, n=267) group. The primary endpoint of this study included major adverse cardiac events (MACEs), such as death, myocardial infarction, or target or nontarget lesion revascularization at one year. Results: There was no difference in clinical characteristics between the two groups. During the one-year follow-up, 102 (15.2%) patients in the COR group and 32 (14.2%) in the MVR group experienced at least one MACE (p=0.330). There were no differences between the two groups in terms of rates of death, myocardial infarction, or revascularization (2.1% vs. 2.0%, 0.7% vs. 0.8%, and 11.7% vs. 10.1%, respectively; p=0.822,0.910, and 0.301, respectively). The MACE rate was higher in the incompletely revascularized patients than in the completely revascularized patients (15% vs. 9.5%, p=0.039), and the difference was attributable to a higher rate of nontarget vessel revascularization (8.6% vs. 1.8%, p=0.002). Conclusion: Although multivessel angioplasty during primary PCI for STEMI did not reduce the MACE rate compared with culprit-vessel-only PCI, CR was associated with a lower rate of repeat revascularization after multivessel PCI.

Original languageEnglish
Pages (from-to)718-725
Number of pages8
JournalKorean Circulation Journal
Volume41
Issue number12
DOIs
Publication statusPublished - 2011 Dec 1

Keywords

  • Angioplasty
  • Coronary artery disease
  • Myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Fingerprint Dive into the research topics of 'Culprit-lesion-only versus multivessel revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction: A Korean Acute Myocardial Infarction Registry-based analysis'. Together they form a unique fingerprint.

  • Cite this

    Jo, H. S., Park, J. S., Sohn, J. W., Yoon, J. C., Sohn, C. W., Lee, S. H., Hong, G. R., Shin, D. G., Kim, Y. J., Jeong, M. H., Chae, S. C., Hur, S. H., Hong, T. J., Seong, I. W., Chae, J. K., Rhew, J. Y., Chae, I. H., Cho, M. C., Bae, J. H., ... Park, S. J. (2011). Culprit-lesion-only versus multivessel revascularization using drug-eluting stents in patients with ST-segment elevation myocardial infarction: A Korean Acute Myocardial Infarction Registry-based analysis. Korean Circulation Journal, 41(12), 718-725. https://doi.org/10.4070/kcj.2011.41.12.718